YTHDF2 and hepatocellular carcinoma: However, Wu Xiaomin et al. also used The Cancer Genome Atlas (TCGA) database for bioinformatics analysis, but they proposed the opposite point of view: ZC3H13 was overexpressed in hepatocellular carcinoma patients, and they used m6A regulators such as YTHDF2, YTHDF1, METTLl3, KIAA1429, and ZC3H13 as prognostic features, which could successfully distinguish high-risk patients with HCC [17].